| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/19/1997 | CN1143319A Compound and methods for treatment of cardiovascular, inflammatory and immune disorders |
| 02/19/1997 | CN1142973A Vaccine composition having antitumour activity and use thereof in therapy of malignant diseases |
| 02/18/1997 | USRE35458 Reacting aqueous solution of copper nitrate and aqueous ethanolic solution of 4,7-diphenyl-1,10-phenanthroline under acidic conditions, adding aqueous solution of amino acid under alkaline conditions to obtain complex |
| 02/18/1997 | US5604261 Having hydroxyl/alkoxyl group ortho to amide group on phenyl ring; high melatonin receptor affinity |
| 02/18/1997 | US5604258 Methods for treating malaria and other diseases |
| 02/18/1997 | US5604248 Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
| 02/18/1997 | US5604247 Chromone Derivatives |
| 02/18/1997 | US5604237 Improve or increase efficacy of antitumor agent, increase or restore sensitivity of tumor to antitumor agent, reverse or reduce resistance of tumor to antitumor agent |
| 02/18/1997 | US5604216 Diluted mixtures for use as drugs or nutritional supplements |
| 02/18/1997 | US5604215 Sulfonated oestrone or dehydroepiandrosterone and derivatives; anti breast cancer agent |
| 02/18/1997 | US5603962 Administering an antitumor agent obtained by actinic irradiation of an aqueous sulfuric acid solution |
| 02/13/1997 | WO1997005270A1 Inhibitors of farnesyl-protein transferase |
| 02/13/1997 | WO1997005250A2 Receptor ligand vegf-c |
| 02/13/1997 | WO1997005239A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | WO1997005169A1 Ha-2 antigenic peptide |
| 02/13/1997 | WO1997005167A1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone |
| 02/13/1997 | WO1997005154A1 Improved therapeutic agents |
| 02/13/1997 | WO1997005127A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 02/13/1997 | WO1997004802A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 02/13/1997 | WO1997004787A1 Liposomal oligonucleotide compositions |
| 02/13/1997 | WO1997004785A1 Use of phenol substituted diphosphonates as antineoplastic agents |
| 02/13/1997 | WO1997004779A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004771A1 Benzimidazole compounds |
| 02/13/1997 | WO1997004763A1 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 02/13/1997 | WO1996035774A3 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/13/1997 | WO1996034969A3 Gene therapy using replication competent targeted adenoviral vectors |
| 02/13/1997 | DE19529612A1 Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate Sulfonyl or sulfinyl derivatives benzoylguanidine |
| 02/13/1997 | CA2228248A1 Receptor ligand vegf-c |
| 02/13/1997 | CA2228212A1 Use of phenol substituted diphosphonates as antineoplastic agents |
| 02/13/1997 | CA2228178A1 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 02/13/1997 | CA2228176A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 02/13/1997 | CA2227989A1 Liposomal oligonucleotide compositions |
| 02/13/1997 | CA2227980A1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone |
| 02/13/1997 | CA2227808A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 02/13/1997 | CA2227369A1 Inhibitors of farnesyl-protein transferase |
| 02/13/1997 | CA2227327A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | CA2225552A1 Quinolones and their therapeutic use |
| 02/13/1997 | CA2225465A1 Benzimidazole compounds |
| 02/13/1997 | CA2224909A1 Ha-2 antigenic peptide |
| 02/12/1997 | EP0757982A1 Biphenylic compounds, process for their preparations and intermediates for this process, their use as 5-alpha-reductase inhibitors and pharmaceutical compositions containing them |
| 02/12/1997 | EP0757689A1 Porphocyanine and cnc-expanded porphyrins |
| 02/12/1997 | EP0757688A1 Method for stabilizing compound dx-52-1 and lyophilized composition thereof |
| 02/12/1997 | EP0757681A1 CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS GnRH ANTAGONISTS |
| 02/12/1997 | EP0757676A1 Dihydrodibenzo(de,h)isoquinolines derivatives and their use as anti-cancer agents |
| 02/12/1997 | EP0757559A1 Composition for delivery of toxic radioisotopes to the cell nucleus and use |
| 02/12/1997 | EP0663908B1 Method of preparing taxane derivatives |
| 02/12/1997 | CN1142505A Anti-idiotypic antibodies which induce immune response against epidermal growth factor receptor |
| 02/11/1997 | US5602275 May be used to accelerate recovery from neutropenia accompanying radio- or chemotherapy, bone marrow transplantation or infections |
| 02/11/1997 | US5602141 Camptothecin derivatives and process for their preparation |
| 02/11/1997 | US5602108 Antitumor agents |
| 02/11/1997 | US5602096 Contacting cell with glial growth factor |
| 02/11/1997 | US5602095 Recombinant pseudomonas exotoxin with increased activity |
| 02/11/1997 | US5601999 Antitumor polysaccharide-glycan complexes |
| 02/11/1997 | US5601989 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 02/11/1997 | US5601981 Methods for determining and agents for modulating cellular redox potential and genotoxic states |
| 02/11/1997 | US5601973 Polypeptides for diagnostic identifying specific antibodies |
| 02/11/1997 | US5601825 Therapeutic conjugates of toxins and drugs |
| 02/11/1997 | US5601818 Administering transformed cancer cells which carry the herpes simplex virus gene for thymidine kinase and are susceptible to an antiviral nucleoside analog, then administering the nucleosside analog to cause tumor regression |
| 02/06/1997 | WO1997004312A1 Compounds and methods related to parathyroid hormone-like protein |
| 02/06/1997 | WO1997004117A1 Liver-specific adenovirus expression vector |
| 02/06/1997 | WO1997004097A2 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | WO1997004092A1 P53 protein variants and therapeutical uses thereof |
| 02/06/1997 | WO1997004085A1 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 02/06/1997 | WO1997003998A1 Modulators of the function of fas receptors and other proteins |
| 02/06/1997 | WO1997003995A1 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 02/06/1997 | WO1997003957A1 Bis-(2-haloethyl)aminophenyl substituted distamycin derivatives as antitumor and antiviral agents |
| 02/06/1997 | WO1997003783A1 Metalloproteinase inhibitors |
| 02/06/1997 | WO1997003703A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | WO1997003701A2 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 02/06/1997 | WO1997003695A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | WO1997003682A1 Method for treating cancers using 6-[3-[1-adamantyl]-4-hydroxyphenyl] |
| 02/06/1997 | WO1997003668A1 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 02/06/1997 | WO1997003666A1 Agent for suppressing tumour growth |
| 02/06/1997 | WO1997003663A1 NON-β-OXIDIZABLE FATTY ACID ANALOGUES, THEIR USES AS THERAPEUTIC ACTIVE MEDICAMENTS, AND PREPARATION THEREOF |
| 02/06/1997 | WO1997003635A2 p16 EXPRESSION CONSTRUCTS AND THEIR APPLICATION IN CANCER THERAPY |
| 02/06/1997 | WO1996029068A3 Use of betulinic acid and its derivatives for inhibiting malignant melanoma growth and a method of monitoring this |
| 02/06/1997 | WO1996013512A3 L-ribofuranosyl nucleosides |
| 02/06/1997 | CA2227592A1 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 02/06/1997 | CA2227334A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | CA2227220A1 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | CA2227193A1 P16 expression constructs and their application in cancer therapy |
| 02/06/1997 | CA2227065A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | CA2227013A1 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 02/06/1997 | CA2226926A1 Liver-specific adenovirus expression vector |
| 02/06/1997 | CA2226871A1 Non-.beta.-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof |
| 02/06/1997 | CA2223489A1 Method for treating cancer using ahpn |
| 02/06/1997 | CA2199635A1 Bis-(2-haloethyl)aminophenyl substituted distamycin derivatives as antitumor and antiviral agents |
| 02/05/1997 | EP0757056A1 Method for preparing 1-beta-D-arabinofuranosylcytosine |
| 02/05/1997 | EP0757055A2 Glycosides, sugar-free degradation products and derivatives of the same |
| 02/05/1997 | EP0757049A1 Camptothecin derivatives |
| 02/05/1997 | EP0756827A2 Composition for nutrition |
| 02/05/1997 | EP0756604A1 Melanoma antigens |
| 02/05/1997 | EP0756488A1 Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment |
| 02/05/1997 | CN1142188A 人生长激素 Human Growth Hormone |
| 02/05/1997 | CN1142186A Use of IL-10 to stimulate peripheral blood mononuclear cell cytolytic activity |
| 02/05/1997 | CN1141921A Chromone derivative |
| 02/05/1997 | CN1033975C Preparation of 2beta, 19-ethylene bridged steroids as aromatase inhibitors |
| 02/04/1997 | US5600007 Photostability for drugs, cosmetics |
| 02/04/1997 | US5599984 Guanylhydrazones and their use to treat inflammatory conditions |
| 02/04/1997 | US5599975 Cyclised analogues of fatty acid metabolites |